Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Asia2G Capital
Silicon ValleySeed–Series A
6 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
11 people
Diffusion Capital Partners
IstanbulPre-Seed–Series A$540K – $2.2M
9 people
Ameba Capital
ShanghaiSeed–Growth
10 people
New Jersey Economic Development Authority
TrentonPre-Seed–Growth
13 people
Healthier Capital
Menlo ParkSeed–Series B
9 people
Seed Healthcare
DoradoSeed–Series A
12 people
TSP Ventures
LondonPre-Seed–Series A
12 people
Verge Fund
AlbuquerquePre-Seed–Series A$100K – $500K
9 people
Welltech Ventures
Tel AvivSeed–Series A
10 people
Zoic Capital
SeattleSeed–Series A
13 people
MedStartr Ventures
New YorkSeed–Series A
11 people
AUM Ventures
IndiaPre-Seed–Series A$750K – $2M
6 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
Narya Capital
ColumbusPre-Seed–Series A
5 people
Nurse Capital
ChicagoPre-Seed–Series A$2M – $5M
9 people
Taiho Ventures, LLC
Menlo ParkSeed–Series A
6 people
Tramway Venture Partners
New MexicoSeed–Series A$30M
9 people
CCV Capital
BeijingSeed–Series B
14 people
NGT Healthcare 2
NazarethSeed–Series A
8 people
Netrix Ventures
Pre-Seed–Series A
2 people
Catalpa Ventures
GrevenmacherPre-Seed–Series A$330K – $1.6M
10 people
Almeda Ventures
Tel AvivSeed–Series A
12 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.

































































































